Common drug may make key fibroid surgery safer
NCT ID NCT07286188
Summary
This study is testing if giving the drug misoprostol before a specific type of fibroid surgery makes the procedure safer. The surgery uses fluid to see inside the uterus, and absorbing too much fluid is a main risk. Researchers want to see if misoprostol helps the uterus contract, reducing fluid absorption so surgeons can complete the operation without hitting safety limits. About 40 women having this surgery will be randomly assigned to receive either the drug or a placebo (inactive pill) beforehand.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYSTEROSCOPY / METHODS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Northwestern
RECRUITINGChicago, Illinois, 60611, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.